|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| A61K 48/005 | (2013.01) | ||
| C12N 15/00 | (2006.01) | ||
| C12N 15/86 | (2013.01) | ||
| C12N 15/11 | (2006.01) | ||
| C07K 16/08 | (2013.01) | ||
| C12N 15/86 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| C12N 15/861 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| C12N 5/02 | (2006.01) | ||
| C12N2750/14143 | (2013.01) | ||
| A61K 48/0075 | (2013.01) |
| (11) | Number of the document | 3448437 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17790633.6 |
| Date of filing the European patent application | 2017-05-01 | |
| (97) | Date of publication of the European application | 2019-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/030364 |
| Date | 2017-05-01 |
| (87) | Number | WO 2017/190125 |
| Date | 2017-11-02 |
| (30) | Number | Date | Country code |
| 201662330002 P | 2016-04-29 | US |
| (72) |
KERAVALA, Annahita , US
CHALBERG, Thomas W , US
|
| (73) |
Adverum Biotechnologies, Inc. ,
800 Saginaw Dr., Redwood City, CA 94063,
US
|
| (54) | EVASION OF NEUTRALIZING ANTIBODIES BY A RECOMBINANT ADENO-ASSOCIATED VIRUS |
| EVASION OF NEUTRALIZING ANTIBODIES BY A RECOMBINANT ADENO-ASSOCIATED VIRUS |